Anxiety Clinical Trials in Arlington, TX

17 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Exploring Virtual Reality Adventure Training Exergaming	N/A	The University of Texas at Arlington	<1 mi
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)	Phase 2	Seaport Therapeutics	11 mi
Massage Therapy After Thoracic or Lumbar Surgery	N/A	Cook Children's Health Care System	12 mi
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	18 mi
Triage Survey for Psychiatry Research Eligibility	—	Adams Clinical	18 mi
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder	Phase 2	Intra-Cellular Therapies, Inc.	18 mi
Clinical Trial on Agitation in Alzheimer's Dementia	Phase 2	IGC Pharma, LLC	18 mi
Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder	N/A	Nader Pouratian	18 mi
Teen Recovery Through Inspiration, Support, and Empowerment	N/A	University of Texas Southwestern Medical Center	18 mi
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder	Phase 2	Intra-Cellular Therapies, Inc.	18 mi
Targeting Social Function in Anxiety and Eating Disorders	N/A	University of Texas Southwestern Medical Center	18 mi
Resilience in Adolescent Development	—	University of Texas Southwestern Medical Center	18 mi
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder	Phase 2	AbbVie	18 mi
Recovery Through Inspiration, Support, and Empowerment	N/A	University of Texas Southwestern Medical Center	18 mi
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder	Phase 2	Reunion Neuroscience Inc	31 mi
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder	Phase 2	VistaGen Therapeutics, Inc.	31 mi
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age	—	State University of New York at Buffalo	31 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.